ITRAQ-Based Serum Proteomic Analysis of Tuina therapy for Neck pain: A randomized controlled study

Hubei Provincial Hospital of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. The main complaint is neck pain stiffness or limited cervical activity and meets the diagnostic criteria;
•2. Aged 18 to 28 years, gender is not limited;
•3. The neck pain VAS score is 3-7;
•4. Voluntary participation in the study and signing of the informed consent.
•Note: subjects with neck pain who meet all the above four criteria are allowed to be included in this study.

•1. A history of trauma such as cervical fracture and dislocation;
•2. Skin damage on neck and shoulder;
•3. Neck pain with numbness, dizziness, nausea, vomiting, blurred vision, palpitation symptoms;
•4. Previous medical history of severe heart, liver, kidney, immune system, blood, digestive system, cancer, tumor, tuberculosis, etc.;
•5. Severe mental disorder;
•6. Pregnancy and lactation;
•7. Are participating in other clinical trials that interfere with this study;
•8. Oral analgesics within one week.
•Note: subjects who meet any of the above criteria will be excluded.

发起方

Hubei Provincial Hospital of TCM